Dismissal of Plaintiff’s Suit for Forum Non Conveniens Affirmed
Eurofins Pharma US Holdings v. BioAlliance Pharma SA, 09-3790, concerned a challenge to the district court’s dismissal of the suit under the doctrine of forum non conveniens, in a dispute involving the acquisition of intellectual property that includes in vitro phenotyping technology that assists in the development and administration of drugs used to treat HIV and Hepatitis B by testing the effectiveness of those drugs on specific patients’ viruses.
Related Link:
- Read the Third Circuit’s Full Decision in Eurofins Pharma US Holdings v. BioAlliance Pharma SA, 09-3790
You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help
Civil Rights
Block on Trump’s Asylum Ban Upheld by Supreme Court
Criminal
Judges Can Release Secret Grand Jury Records
Politicians Can’t Block Voters on Facebook, Court Rules
